Table 2.
Predictors for sVT in patients with ACM.
| Variable | Prediction model | ||
|---|---|---|---|
| β | Odds ratio (95% CI) | P-value | |
| TWI-A | 1.38 | 3.97 (1.148–15.647) | 0.04 |
| LnSDNN | −2.19 | 0.11 (0.011–0.813) | 0.04 |
| Male | 2.81 | 16.62 (3.613–108.370) | <0.001 |
| Heart failure | −4.43 | 0.01 (0.001–0.155) | 0.002 |
| LVEF | −0.11 | 0.90 (0.818–0.978) | 0.02 |
| Syncope | 1.01 | 2.73 (0.698–11.527) | 0.15 |
| Age | 0.02 | 1.02 (0.970–1.071) | 0.44 |
sVT, sustained ventricular tachycardia; ACM, arrhythmogenic cardiomyopathy; CI, confidence interval; TWI-A, T wave inversion on anterior leads; TWI-I, T wave inversion on inferior leads; NSVT, non-sustained ventricular tachycardia; LVDD, left ventricular end diastolic dimension; LVEF, left ventricular ejection fraction; RV, right ventricle; PAH, pulmonary artery hypertension; NSVT, non-sustained ventricular tachycardia; SDNN, Standard deviation of NN intervals; NA, not available.